The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms
Document Type
Journal Article
Publication Date
2003
Journal
Sleep
Volume
26
Issue
2
Inclusive Pages
131-135
Keywords
Neurology
APA Citation
Emsellem, H. (2003). The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms. Sleep, 26 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_neuro_facpubs/605
COinS